Vistagen Therapeutics (VTGN) Return on Capital Employed [ROCE] (2017 - 2026)
Vistagen Therapeutics (VTGN) reported Return on Capital Employed [ROCE] of -225.03% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 133.93 percentage points from -91.09% a year earlier and down 61.17 percentage points from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Return on Capital Employed [ROCE] of -134.42%, down 73.17 percentage points from FY2025.
- Return on Capital Employed [ROCE] has a five-year change of -100.48 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Capital Employed [ROCE] came in at -61.25% in FY2025 (-12.15 pp), -49.10% in FY2024 (+87.80 pp), -136.90% in FY2023 (-81.15 pp) and -55.75% in FY2022 (-21.81 pp).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q1 2024.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last seven quarters, with an average year-over-year change of -46.50 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q1 2025 (a gain of 297.86 percentage points); the low point was fiscal Q1 2024 (a drop of 228.28 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -163.85% (Q4 2026), -117.55% (Q3 2026) and -106.84% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | -225.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -225.03% |
| Mar 31, 2026 | -163.85% |
| Dec 31, 2025 | -117.55% |
| Sep 30, 2025 | -106.84% |
| Jun 30, 2025 | -91.09% |
| Mar 31, 2025 | -73.93% |
| Dec 31, 2024 | -60.19% |
| Sep 30, 2024 | -45.37% |
| Jun 30, 2024 | -33.96% |
| Mar 31, 2024 | -27.01% |
| Dec 31, 2023 | -41.11% |
| Sep 30, 2023 | -139.21% |
| Jun 30, 2023 | -331.82% |
| Mar 31, 2023 | -284.60% |
| Dec 31, 2022 | -206.10% |
| Sep 30, 2022 | -147.69% |
| Jun 30, 2022 | -103.54% |
| Mar 31, 2022 | -62.19% |
| Dec 31, 2021 | -41.87% |
| Sep 30, 2021 | -34.01% |
API Access
Vistagen Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();